These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6149573)

  • 41. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
    Siegel RC; Schumaker VN; Poon PH
    J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.
    Perkins SJ
    Biochem J; 1985 May; 228(1):13-26. PubMed ID: 2988513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q.
    Lu JH; Thiel S; Wiedemann H; Timpl R; Reid KB
    J Immunol; 1990 Mar; 144(6):2287-94. PubMed ID: 2313094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity.
    Arlaud GJ; Gaboriaud C; Thielens NM; Budayova-Spano M; Rossi V; Fontecilla-Camps JC
    Mol Immunol; 2002 Nov; 39(7-8):383-94. PubMed ID: 12413689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biochemical data on C1 intrinsic activation (author's transl)].
    Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
    Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent.
    Zapf S; Loos M
    Immunobiology; 1985 Sep; 170(3):123-32. PubMed ID: 3932188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
    Hoekzema R; Martens M; Brouwer MC; Hack CE
    Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deficiency of the first component of human complement.
    Reid KB
    Immunodefic Rev; 1989; 1(3):247-60. PubMed ID: 2561058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
    Busby TF; Ingham KC
    Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease.
    Loos M; Colomb M
    Behring Inst Mitt; 1993 Dec; (93):1-5. PubMed ID: 8172555
    [No Abstract]   [Full Text] [Related]  

  • 56. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and function of complement activating enzyme complexes: C1 and MBL-MASPs.
    Gál P; Ambrus G
    Curr Protein Pept Sci; 2001 Mar; 2(1):43-59. PubMed ID: 12369900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
    J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.